Works by Ansell, Stephen
Results: 247
Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01173-w
- By:
- Publication type:
- Article
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
- By:
- Publication type:
- Article
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00895-7
- By:
- Publication type:
- Article
Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
- By:
- Publication type:
- Article
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
- By:
- Publication type:
- Article
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
- Published in:
- 2022
- By:
- Publication type:
- Letter
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
- By:
- Publication type:
- Article
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0246-0
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 705, doi. 10.1016/j.clml.2023.06.006
- By:
- Publication type:
- Article
Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 138, doi. 10.1016/j.clml.2022.11.004
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
- By:
- Publication type:
- Article
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
- By:
- Publication type:
- Article
CT-387: Prognostic Role of Lymphocyte to Monocyte Ratio in Pts Treated with CAR-T for Aggressive Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S453, doi. 10.1016/S2152-2650(21)02005-X
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S373, doi. 10.1016/S2152-2650(21)01854-1
- By:
- Publication type:
- Article
HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8
- By:
- Publication type:
- Article
Poster: CT-387: Prognostic Role of Lymphocyte to Monocyte Ratio in Pts Treated with CAR-T for Aggressive Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01622-0
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S237, doi. 10.1016/S2152-2650(21)01489-0
- By:
- Publication type:
- Article
Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
From Biology to Therapy: Progress in Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S180, doi. 10.1016/S2152-2650(21)01258-1
- By:
- Publication type:
- Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Metformin Use on the Outcome of Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S270, doi. 10.1016/j.clml.2018.07.192
- By:
- Publication type:
- Article
Treatment of Relapsed Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S88, doi. 10.1016/j.clml.2018.06.066
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome of Transformed Diffuse Large B-Cell Lymphoma in the Rituximab Era: A SEER Database Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S362, doi. 10.1016/j.clml.2017.07.196
- By:
- Publication type:
- Article
Jak/Stat pathway in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Jak/Stat Pathway in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 112, doi. 10.3816/CLML.2011.n.023
- By:
- Publication type:
- Article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
- By:
- Publication type:
- Article
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 6, p. 628, doi. 10.1111/j.1365-2141.2006.06088.x
- By:
- Publication type:
- Article
Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 3, p. 629, doi. 10.1046/j.1365-2141.2002.03478.x
- By:
- Publication type:
- Article
Thalidomide treatment in myelofibrosis with myeloid metaplasia.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 2, p. 288, doi. 10.1046/j.1365-2141.2002.03443.x
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1808, doi. 10.3390/biomedicines12081808
- By:
- Publication type:
- Article
Day 100 Natural Killer Cell/CD14+HLA‐DR<sup>DIM</sup> ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 1, p. 1, doi. 10.1111/ctr.15211
- By:
- Publication type:
- Article
Neo- and Paleopolyploidy contribute to the species diversity of Asplenium-the most species-rich genus of ferns.
- Published in:
- Journal of Systematics & Evolution, 2017, v. 55, n. 4, p. 353, doi. 10.1111/jse.12271
- By:
- Publication type:
- Article
Exploring the utility of three nuclear regions to reconstruct reticulate evolution in the fern genus Asplenium.
- Published in:
- Journal of Systematics & Evolution, 2013, v. 51, n. 2, p. 142, doi. 10.1111/j.1759-6831.2012.00226.x
- By:
- Publication type:
- Article